TrialJournal of bone and mineral metabolism2017

Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis.

Masataka Shiraki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.